U

University of North Carolina at Chapel Hill | Lineberger Comprehensive Cancer Center

Research site
(Unclaimed)
Location
720 Martin Luther King Junior Boulevard, Chapel Hill, North Carolina, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 7
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas

The purpose of this study is to test whether giving acalabrutinib is safe and effective in controlling relapsed central nervous system (CNS) lymphoma...

Enrolling
Central Nervous System Lymphoma
Drug: Acalabrutinib
Drug: Isavuconazole

This study is researching an experimental drug called REGN3767, also known as fianlimab (R3767), when combined with another medication called cemipli...

Enrolling
Melanoma
Drug: Pembrolizumab
Drug: Placebo

This research study aims to evaluate the safety and effectiveness of the combination of isatuximab, pomalidomide, and dexamethasone (Isa-Pd) for the...

Enrolling
Aging
Multiple Myeloma
Drug: Pomalidomide
Drug: Isatuximab

Endometrial cancer (EC) is the fourth most common cancer in United States women, and alarmingly, the frequency and mortality from EC continues to ris...

Enrolling
Endometrial Cancer
Metastasis
Drug: ONC201
Drug: Atezolizumab

Trial conditions

Lymphoma (2 trials)
Endometrial Cancer (1 trial)
Leukocytosis (1 trial)
Leukopenia (1 trial)
Melanoma (1 trial)
Multiple Myeloma (1 trial)
Neutropenia (1 trial)
Obesity (1 trial)
Ovarian Epithelial Carci... (1 trial)
Ovarian Cancer (1 trial)

And 1 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems